Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Themis Medicare Ltd.

NSE: THEMISMED | BSE:530199

₹212.72 7.01 (3.41%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

198.60

Today’s High

213.80

52W low

135.60

52W High

263.80

Open Price

206.80

Prev. Close

210.9500

Volume

189817.00

Value

40377872.24

Fundamentals

Market Cap

1957.90

Price to Earnings

45.00

Price to Book Value

5.20

Dividend Yield

0.20

PE to Growth

-1.90

Op Revenue TTM

381.76

Net Profit TTM

43.52

Cash From Operating Activity

22.09

Return on Equity %

11.52

EMA & SMA

Bullish Moving Averages

12

Bearish Moving Averages

4

5Day EMA

209.8

10Day EMA

211

12Day EMA

211.4

20Day EMA

212

26Day EMA

212.2

50Day EMA

213

100Day EMA

212

200Day EMA

200.4

5Day SMA

208.9

10Day SMA

211.3

20Day SMA

214.7

30Day SMA

211.8

50Day SMA

211.7

100Day SMA

218.9

150Day SMA

214.6

200Day SMA

202.4

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

52

Week

56

Month

62.7

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

208.37

PIVOT

First Resistance

218.19

Second Resistance

223.66

Third Resistance

233.48

First Support

202.90

Second Support

193.08

Third Support

187.61

Relative Strength Index

50.56

Money Flow Index

54.19

MACD

-0.8

MACD Signal

0.14

Average True Range

9.03

Average Directional Index

15.28

Rate of Change (21)

4.48

Rate of Change (125)

-2.42

Commodity Channel Index

-98.7

Williams %R

-50.1

BETA

1 Month

1.05

3 Month

1.27

1 Year

1.11

3 Year

0.42

PRICE CHANGE ANALYSIS

↑ 1.41%

1 Week

Low

High

198.55

215.25

↑ 11.55%

1 Month

Low

High

180.55

226.93

↓ -6.35%

3 Months

Low

High

180.55

234.35

↓ -1.4%

6 Months

Low

High

180.55

263.85

↑ 56.4%

1 Year

Low

High

135.59

263.85

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 98.92 83.08 107.22 97.30 83.05 94.68 92.98 95.12 81.64 99.06 107.60
Operating Expenses Qtr 88.50 74.45 92.38 74.90 69.62 73.51 69.66 74.08 65.38 77.63 83.93
Operating Profit Qtr 9.31 8.07 12.41 21.74 10.49 15.27 21.34 20.36 14.42 17.29 23.46
EBIDT Qtr Cr 10.41 8.63 14.85 22.40 13.43 21.17 23.32 21.04 16.26 21.43 23.68
Depreciation Qtr 3.06 3.10 3.07 3.02 2.80 2.67 2.56 2.46 2.39 2.37 2.38
Net Profit Qtr 3.09 2.00 7.10 12.56 6.04 12.09 13.53 11.63 7.55 12.15 15.12
Basic EPS Qtr 0.34 0.22 7.71 13.64 6.57 13.14 14.71 12.64 8.21 13.21 16.44
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 386.52 365.83 401.16 234.29 205.06
Operating Expenses Annual Cr 330.23 286.86 298.96 180.79 165.91
Operating Profit Annual 51.53 67.46 95.65 49.88 35.68
Operating Profit Margin Annual % 13.33 18.44 23.84 21.29 17.40
Total Expenses Annual Cr 351.85 306.92 317.22 202.04 187.05
EBIDT Annual Cr 56.29 78.97 102.19 53.51 39.15
EBIDT Annual margin % 14.56 21.59 25.47 22.84 19.09
Depreciation 12.25 10.49 9.48 8.55 8.27
PAT Before ExtraOrdinary Items Annual Cr 24.75 43.29 61.56 26.62 15.91
Net Profit Annual 24.75 43.29 61.56 26.62 15.91
Basic EPS Annual 2.69 47.05 66.91 28.97 17.32
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 301.28 281.83 243.48 185.80 159.31
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 34.17 35.39 30.77 24.33 12.08
Total Current Liabilities Annual Cr 154.52 139.07 109.48 128.27 154.79
Total Capital Plus Liabilities Annual Cr 489.97 456.29 383.74 338.40 326.18
Fixed Assets Annual 170.96 164.80 146.56 135.57 123.84
Total Non Current Assets Annual 195.52 190.49 168.32 151.69 144.90
Total Current Assets Annual 294.44 265.80 215.42 186.72 181.28
Total Assets Annual 489.97 456.29 383.74 338.40 326.18
Contingent Liabilities plus Commitments Annual Cr 18.76 18.75 9.39 16.56 12.77
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 22.04 16.07 34.39 56.98 0.33
Cash from Investing Activity Annual -15.96 -23.96 -15.58 -15.65 -5.46
Cash from Financing Annual Activity -8.77 0.14 -17.55 -25.65 6.72
Net Cash Flow Annual -2.68 -7.75 1.26 15.68 1.60
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 32.73 306.24 264.64 202.21 173.39
ROE Annual % 8.21 15.36 25.28 14.32 9.98
ROCE Annual % 13.12 21.58 33.80 21.39 18.01
Total Debt to Total Equity Annual 0.32 0.33 0.32 0.43 0.56
EBDIT Annual Margin % 14.74 22.28 25.89 23.19 19.42
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 98.92 83.08 107.22 97.30 83.05 94.68 92.98 95.12 81.64 99.06 107.60
Operating Expenses Qtr 88.52 74.45 92.38 74.91 69.62 73.51 69.66 74.08 65.39 77.63 83.93
Operating Profit Qtr 9.30 8.06 12.41 21.74 10.48 15.27 21.34 20.36 14.41 17.29 23.46
EBIDT Qtr Cr 10.40 8.63 14.84 22.39 13.43 21.17 23.32 21.04 16.25 21.43 23.67
Depreciation Qtr 3.06 3.10 3.07 3.02 2.80 2.67 2.56 2.46 2.39 2.37 2.38
Net Profit Qtr 6.64 7.37 11.32 18.19 8.41 13.31 17.78 17.40 9.95 12.46 19.28
Basic EPS Qtr 0.72 0.80 12.30 19.77 9.13 14.47 19.33 18.92 10.81 13.54 20.95
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 386.52 365.83 401.16 234.29 205.05
Operating Expenses Annual Cr 330.26 286.87 298.98 181.18 165.93
Operating Profit Annual 51.51 67.45 95.64 49.49 35.66
Operating Profit Margin Annual % 13.33 18.44 23.84 21.12 17.39
Total Expenses Annual Cr 351.88 306.93 317.23 202.44 187.08
EBIDT Annual Cr 56.26 78.96 102.18 53.12 39.12
EBIDT Annual margin % 14.56 21.58 25.47 22.67 19.08
Depreciation 12.25 10.49 9.48 8.55 8.27
PAT Before ExtraOrdinary Items Annual Cr 24.72 43.28 61.54 26.23 15.88
Net Profit Annual 43.52 56.90 72.88 35.70 24.78
Basic EPS Annual 4.73 61.83 79.22 38.84 26.97
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 377.67 339.44 287.49 218.51 183.02
Minority Interest Liability Annual Cr -0.00 -0.00 -0.00 -0.00 -0.00
Total Non Current Liabilities Annual Cr 34.17 35.39 30.77 24.33 12.08
Total Current Liabilities Annual Cr 154.58 139.13 109.52 128.31 154.81
Total Capital Plus Liabilities Annual Cr 566.42 513.96 427.78 371.14 349.91
Fixed Assets Annual 170.97 164.80 146.56 135.57 123.85
Total Non Current Assets Annual 273.25 249.43 213.62 185.67 169.42
Total Current Assets Annual 293.17 264.53 214.16 185.47 180.49
Total Assets Annual 566.42 513.96 427.78 371.14 349.91
Contingent Liabilities plus Commitments Annual Cr 18.76 18.75 13.75 16.56 12.77
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 22.09 16.09 34.39 56.98 0.33
Cash from Investing Activity Annual -15.95 -23.96 -15.59 -15.65 -5.47
Cash from Financing Annual Activity -8.77 0.14 -17.55 -25.65 6.72
Net Cash Flow Annual -2.62 -7.73 1.26 15.68 1.59
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 41.03 368.85 312.48 237.80 199.20
ROE Annual % 11.52 16.76 25.35 16.33 13.54
ROCE Annual % 10.68 18.26 29.12 18.35 15.81
Total Debt to Total Equity Annual 0.25 0.27 0.27 0.36 0.48
EBDIT Annual Margin % 14.73 22.28 25.89 23.02 19.40
Name Holding Percent Holding Id Pledged % Locked %
Anuj Anantrai Sheth 4.89 75045145 - -
Name Holding Percent Holding Id Pledged % Locked %
Dinesh Shantilal Patel 9.47 75045118 0 0
Jayshree D Patel 7.25 75045119 0 0
Sachin Dinesh Patel 5.99 75045120 0 0
Reena S Patel 4.04 75045121 0 0
Anay Rupen Choksi 1.28 75045122 0 0
Nysha Rupen Choksi 1.28 75045123 0 0
Dinesh S Patel HUF 1.07 75045124 0 0
Shantilal Dahyabhai Patel HUF 0.61 75045125 0 0
Vividhmargi Investments Pvt 15.78 75045128 10.32 0
Gedeon Richter Investment Management Ltd. 9.61 75045132 0 0
Vividh Distributors Private Ltd. 7.78 75045129 0 0
Themis Distributors Private Ltd. 2.98 75045130 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
Anuj Anantrai Sheth 4.89 75045145
Jagat Navratna Lodha 1.32 75045146
HUF 1.66 75045138
Za Capital Services India Private Ltd 1.59 75045142
Zafar Ahmadullah 2.34 75045148
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 01, 2023 5 FINAL - Equity Share
Sep 08, 2022 5 FINAL - Equity Share
Sep 08, 2021 4.3 FINAL - Equity Share
Sep 17, 2020 1.75 FINAL - Equity Share
Jul 20, 2011 3 FINAL - Equity Share
Jun 16, 2010 3 FINAL - Equity Share
Aug 01, 2008 2.5 FINAL - Equity Share
Sep 14, 2007 2 FINAL - Equity Share
Sep 01, 2006 1.5 FINAL - Equity Share
Aug 03, 2005 2.5 FINAL - Equity Share
Aug 19, 2004 2 FINAL - Equity Share
Sep 19, 2003 2 FINAL - Equity Share
Sep 17, 2002 - FINAL - Equity Share
Aug 16, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Oct 10, 2023 10:1 2023-10-10
Ex-Date Purpose Notes
May 14, 2024 Audited Results & Final Dividend -
Feb 10, 2024 Quarterly Results -
Nov 04, 2023 Quarterly Results -
Aug 10, 2023 Quarterly Results (Revised)
May 13, 2023 Audited Results, Dividend & Stock Split -
Feb 03, 2023 Quarterly Results -
Nov 07, 2022 Quarterly Results -
Jul 28, 2022 Quarterly Results -
May 21, 2022 Audited Results & Final Dividend -
Feb 11, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Aug 13, 2021 Quarterly Results -
May 27, 2021 Audited Results & Final Dividend -
Feb 12, 2021 Quarterly Results -
Nov 11, 2020 Quarterly Results -
Aug 14, 2020 Quarterly Results -
Jun 08, 2020 Audited Results & Final Dividend -
Feb 07, 2020 Quarterly Results -
Nov 14, 2019 Quarterly Results -
Aug 07, 2019 Quarterly Results -
May 28, 2019 Audited Results -
Feb 08, 2019 Quarterly Results -
Nov 14, 2018 Quarterly Results -
Aug 08, 2018 Quarterly Results -
May 09, 2018 Audited Results -
Mar 27, 2018 Others To discuss business operations of the Company.
Feb 05, 2018 Quarterly Results -
Dec 12, 2017 Quarterly Results -
Sep 27, 2017 Others To consider appointment of Secretarial Auditors for the Financial Year 2017-18 and to discuss and consider Business Plan of the Company.
Sep 04, 2017 Quarterly Results -
Aug 21, 2017 Others -
May 10, 2017 Audited Results -
Mar 28, 2017 Others To discuss business operations of the Company.
Feb 20, 2017 Others Regarding Change in the Board of Directors of the Company.
Feb 14, 2017 Quarterly Results -
Nov 08, 2016 Quarterly Results -
Sep 14, 2016 Allotment of Shares -
Aug 11, 2016 Quarterly Results -
Jun 17, 2016 Allotment of Equity shares Allotment of 1,25,000 Convertible Warrants of Rs. 500/- each to Promoters of the Company to be issued on preferential basis under the SEBI( Issue of Capital & Disclosure Requirements Regulations).
May 14, 2016 Others To consider and approve a proposal to issue convertible warrants to Promoters of the Company as well as to take such appropriate approvals to give effect to the above proposal.
May 11, 2016 Audited Results & Others A proposal for issue of Equity Shares of the Company on preferential basis to the Non-Promoters.
Mar 30, 2016 Others To review the normal business operations of the Company (Revised 31/03/2016)
Feb 10, 2016 Quarterly Results Approved allotment of 9700 Equity Shares of Rs. 10/- each fully paid up to employees who have exercised their options under THEMIS MEDICARE ESOS, 2012.
Nov 05, 2015 Quarterly Results Interalia, has approved allotment of 18900 Equity Shares of Rs. 10/- each fully paid up to employees who have exercised their option under THEMIS MEDICARE ESOS, 2012.
Sep 21, 2015 Others To review the operations of the Company.
Aug 11, 2015 Quarterly Results Allotment of 18040 Equity shares of Rs. 10/- each fully paid up to employees who have exercised their option under THEMIS MEDICARE ESOS, 2012.
May 27, 2015 Audited Results Reappointment of Dr. Dinesh S. Patel as CEO & Managing Director as well as Dr. Sachin D Patel as Deputy Managing Director.
Mar 17, 2015 Others To review the normal business operations of the Company.
Feb 06, 2015 Quarterly Results & Allot Equity Shares To allot Equity Shares to eligible employees of the Company, who have exercised the ESOP options.
Nov 04, 2014 Quarterly Results -
Sep 29, 2014 Others To allot Equity Shares to eligible employees of the Company, who have exercised the ESOP options.
Aug 06, 2014 Quarterly Results -
May 14, 2014 Audited Results -
Apr 01, 2014 General General Purpose
Feb 10, 2014 Quarterly Results -
Jan 15, 2014 Conversion of Preferential Warrants To consider and approve the conversion of Preferential Warrants issued to the Promoters on July 16, 2012 into equity shares on completion of 18 months.
Nov 11, 2013 Quarterly Results -
Aug 12, 2013 Quarterly Results -
May 15, 2013 Audited Results -
Feb 05, 2013 Quarterly Results -
Nov 10, 2012 Quarterly Results -
Jul 31, 2012 Quarterly Results -
Jun 02, 2012 Issue of convertible warrants To discuss and approve a proposal to issue Convertible Warrants on preferential basis to the Indian Promoters of the Company.
May 12, 2012 Audited Results -
Jan 31, 2012 Quarterly Results -
Dec 23, 2011 Others The Board has considered and approved the proposal for acceptance of fresh public Deposits by the Company.
Nov 04, 2011 Quarterly Results -
Jul 30, 2011 Quarterly Results -
May 03, 2011 Audited Results & Dividend -
Jan 31, 2011 Quarterly Results -
Nov 11, 2010 Quarterly Results -
Jul 31, 2010 Quarterly Results -
Apr 27, 2010 Audited Results & Dividend The Board has recommended Dividend of Rs. 3 per Share (i.e. @ 30%) on Equity Shares as well as transfer to General Reserve of Rs. 3 Crs.
Jan 29, 2010 Quarterly Results -
Oct 30, 2009 Quarterly Results -
Jul 31, 2009 Audited & Quarterly Results -
Apr 30, 2009 Scheme of Arrangement To discuss scheme of arrangement between the Company and its members under section 391 read with section 78, 100 and other applicable provisions of the Companies Act, 1956.
Apr 07, 2009 Scheme of Arrangement To discuss scheme of arrangement between the Company and its members under section 391 read with section 78, 100 and other applicable provisions of the Companies Act, 1956.
Mar 20, 2009 To discuss normal Business Agenda -
Jan 30, 2009 Quarterly Results -
Oct 25, 2008 Quarterly Results -
Oct 03, 2008 To accept of Public Deposits To consider a proposal of Acceptance of Public Deposits & to accept the resignation of Shri. K T Lakdawala, from the Directors of the Company.
Jul 31, 2008 Quarterly Results -
Jun 18, 2008 Dividend -
May 02, 2008 General -
Jan 19, 2008 Quarterly Results -
Oct 22, 2007 Quarterly Results -
Jul 18, 2007 Quarterly Results -
Jun 29, 2007 Audited Results -
Apr 27, 2007 General -
Jan 30, 2007 Quarterly Results -
Oct 28, 2006 To consider Issue of Warrants Proposed to discuss and decide upon issue of warrants to promoters including the terms and conditions thereof, number of warrants to be issued for Preferential Issue of SEBI.
Jul 29, 2006 Quarterly Results -
Jun 09, 2006 Accounts -
Apr 25, 2006 Others For clause 49 of the corporate governance
Jan 23, 2006 Re-issue of forfeited shares -
Oct 21, 2005 Quarterly Results -
Jul 30, 2005 Quarterly Results -
Jun 16, 2005 Accounts -
Jan 20, 2005 Quarterly Results -
Oct 26, 2004 Half Yearly Results -
Jul 19, 2004 Quarterly Results -
Jun 29, 2004 Accounts -
Jan 28, 2004 Quarterly Results -
Oct 17, 2003 Quarterly Results -
Jul 28, 2003 Quarterly Results & Others Matters arising out of merger proposal of Artemis Biotech with the Company.
Jun 12, 2003 Accounts -
Jan 28, 2003 Quarterly Results -
Oct 25, 2002 Quarterly Results -
Jul 19, 2002 Quarterly Results & Others To forfeit the equity shares on which the members have not paid allotment money till date.
May 10, 2002 Dividend & Accounts -
Mar 08, 2002 Interim Dividend -
Jan 18, 2002 Quarterly Results -
Oct 25, 2001 Quarterly Results -
Aug 14, 2001 Quarterly Results -
Jul 24, 2001 Quarterly Results (Revised)
Jun 28, 2001 Accounts -
Jan 29, 2001 Quarterly Results -
Oct 24, 2000 Quarterly Results -
Jul 31, 2000 Quarterly Results -
May 12, 2000 Accounts -
Mar 30, 2000 Interim Dividend -
Jan 27, 2000 Quarterly Results -
Oct 30, 1999 Quarterly Results -
Aug 31, 1999 Accounts -
Aug 14, 1999 Accounts -
Apr 29, 1999 Quarterly Results -
Jan 21, 1999 Quarterly Results -
Oct 30, 1998 Quarterly Results -
Aug 28, 1998 Accounts -
Feb 27, 1998 Half Yearly Results -
Sep 29, 1997 Accounts -
Ex-Date Bonus Ratio Record Date
Bigul
28 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 Please refer to the intimation of closure of Trading Window.
Bigul
28 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 Please refer to the intimation of closure of Trading Window.
Bigul
26 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please refer to attachment for the Newspaper Publication of 54th Annual General Meeting of the Company.
Bigul
25 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Business Responsibility and Sustainability Reporting (BRSR)

 Please refer to the attachment
Bigul
25 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Reg. 34 (1) Annual Report.

 As per the file attached.
Bigul
25 Jun 2024

THEMIS MEDICARE LTD. - 530199 - 54Th Annual General Meeting On 22Nd July, 2024

 Please find our Notice of 54th AGM and Annual Report for the Financial Year 2023-24
Bigul
06 Jun 2024

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Change in Management

 Please find our intimation on the captioned subject.
Bigul
27 May 2024

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Please refer to the attached Annual Secretarial Compliance Report for the F.Y. 2023-24
Bigul
17 May 2024

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Kindly refer the attached file.
Bigul
15 May 2024

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Investor Presentation

 As per the attached file.
See all News

FAQs

The latest market price of Themis Medicare Ltd. on NSE was Rs. 212.72 as of today.

The opening share price of Themis Medicare Ltd. was Rs. 206.80 as of today.

The 52-week high share price of Themis Medicare Ltd. was Rs. 263.80.

The 52 week low share price of Themis Medicare Ltd. was Rs. 135.60.

Please find Corporate actions section for more details.

The PE ratio of Themis Medicare Ltd. is -1.90. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Themis Medicare Ltd. was on 2023-09-01 for Rs. 5 per share. According to today’s share price, the dividend yield of Themis Medicare Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Themis Medicare Ltd. was as of 2023-10-10. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Themis Medicare Ltd..

Close

Let's Open Free Demat Account